Muscular Dystrophy Association Seeks LOIs for MD Research

The Muscular Dystrophy Association is the world's leading nonprofit health agency dedicated to finding treatments and cures for muscular dystrophy, amyotrophic lateral sclerosis (ALS), and other neuromuscular diseases. It advances this mission by funding research; providing comprehensive healthcare services and support to MDA families nationwide; and rallying communities to fight back through advocacy, fundraising, and local engagement.

To that end, MDA is accepting Letters of Intent for its biannual Research Grants program. Research grants are presented to established investigators for projects focused on developing treatments for  muscular dystrophies and related diseases of the neuromuscular system. Awards are typically in the amount of $100,000 per year for one to three years.

To be eligible, an applicant must hold a Doctor of Medicine (MD), Doctor of Philosophy (PhD), Doctor of Science (DSc), or equivalent degree (i.e., DO); be a professional or faculty member (professor, associate professor, or assistant professor) at an appropriate educational, medical, or research institution; be qualified to conduct and mentor a program of original research within his or her own laboratory; assume both administrative and financial responsibility for the grant; and have access to institutional resources needed to conduct the proposed research project.

Proposals from applicants outside the United States will be considered if the project is of high priority to MDA and when (in addition to the applicant's having met the requirements noted above) the applicant's country of residence may not have adequate sources of financial support for biomedical research.

Letters of Intent must be received no later than June 15. Upon review, selected applicants will be invited to submit a full proposal by July 15, 2018.

See the MDA website for complete program guidelines, a list of currently funded projects, tips for crafting a successful proposal, and application instructions.


Deadline: August 01, 2018